In last trading session, Applied Dna Sciences Inc (NASDAQ:APDN) saw 36.35 million shares changing hands with its beta currently measuring 0.43. Company’s recent per share price level of $0.06 trading at -$0.09 or -56.80% at ring of the bell on the day assigns it a market valuation of $3.50M. That closing price of APDN’s stock is at a discount of -19500.0% from its 52-week high price of $11.76 and is indicating a discount of -100.0% from its 52-week low price of $0.12. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 4.7 million shares which gives us an average trading volume of 4.25 million if we extend that period to 3-months.
For Applied Dna Sciences Inc (APDN), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 3.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.06 in the current quarter.
Applied Dna Sciences Inc (NASDAQ:APDN) trade information
Upright in the red during last session for losing -56.80%, in the last five days APDN remained trading in the red while hitting it’s week-highest on Tuesday, 03/11/25 when the stock touched $0.06 price level, adding 59.97% to its value on the day. Applied Dna Sciences Inc’s shares saw a change of -68.87% in year-to-date performance and have moved -50.51% in past 5-day. Applied Dna Sciences Inc (NASDAQ:APDN) showed a performance of -62.71% in past 30-days. Number of shares sold short was 3.0 million shares which calculate 1.58 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 1.5 to the stock, which implies a rise of 96.0% to its current value. Analysts have been projecting 1.5 as a low price target for the stock while placing it at a high target of 1.5. It follows that stock’s current price would drop -2400.0% in reaching the projected high whereas dropping to the targeted low would mean a loss of -2400.0% for stock’s current value.
Applied Dna Sciences Inc (APDN) estimates and forecasts
This year revenue growth is estimated to rise 53.99% from the last financial year’s standing.
1 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 1.19M for the same. And 1 analysts are in estimates of company making revenue of 1.28M in the next quarter. Company posted 929.63k and 797.52k of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 60.68% during past 5 years.
Applied Dna Sciences Inc (NASDAQ:APDN)’s Major holders
Insiders are in possession of 19.47% of company’s total shares while institution are holding 26.90 percent of that, with stock having share float percentage of 33.41%. Investors also watch the number of corporate investors in a company very closely, which is 26.90% institutions for Applied Dna Sciences Inc that are currently holding shares of the company. MATHER GROUP, LLC. is the top institutional holder at APDN for having 700.0 shares of worth $287.0. And as of 2024-06-30, it was holding 0.0803 of the company’s outstanding shares.
